Benue, with Nigeria’s heaviest HIV treatment burden, launches long-acting prevention drug

AI Summary

The Benue State Government has initiated the launch of Lenacapavir, a long-acting injectable HIV prevention drug, aimed at significantly reducing new infections in a state with the highest HIV treatment burden in Nigeria. The initiative is part of a broader goal to eliminate AIDS by 2030.

The Benue State Government has launched Lenacapavir, a long-acting injectable drug for HIV prevention, as part of efforts to curb new infections and end AIDS by 2030. The post Benue, with Nigeria’s heaviest HIV treatment burden, launches long-acting prevention drug appeared first on Premium Times Nigeria.